17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[1'-N-methyl-(2'-indolyl)acetamido]morphinan

ID: ALA3319611

Chembl Id: CHEMBL3319611

PubChem CID: 118709684

Max Phase: Preclinical

Molecular Formula: C30H33N3O4

Molecular Weight: 499.61

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1c(C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc2ccccc21

Standard InChI:  InChI=1S/C30H33N3O4/c1-32-21-5-3-2-4-18(21)14-22(32)28(35)31-20-10-11-30(36)24-15-19-8-9-23(34)26-25(19)29(30,27(20)37-26)12-13-33(24)16-17-6-7-17/h2-5,8-9,14,17,20,24,27,34,36H,6-7,10-13,15-16H2,1H3,(H,31,35)/t20-,24-,27+,29+,30-/m1/s1

Standard InChI Key:  AQCARSNGEIBNGP-YFKGXFAISA-N

Alternative Forms

1. Parent:

   

   ALA3319611

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 499.61

Molecular Weight (Monoisotopic): 499.2471

AlogP: 3.25

#Rotatable Bonds: 4

Polar Surface Area: 86.96

Molecular Species: BASE

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.29

CX Basic pKa: 9.51

CX LogP: 2.61

CX LogD: 0.79

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.51

Np Likeness Score: 0.59

References

1. Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, Portoghese PS..  (2014)  Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.,  57  (15): [PMID:24978316] [10.1021/jm500159d]

Source

Source(1):

• Scientific Literature